Visugromab (Powder)
Gecertificeerd

Visugromab (Powder)

Catalog #: HY-P99100A
Maat: 1 Each

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100

Technische Specificaties

Description

Visugromab (CTL-002) (Powder) is a GDF-15 neutralizing IgG4 mAb. Visugromab (Powder) has synergistic anticancer activity with the anti-PD1 antibody Nivolumab and can effectively act on PD-1/PD-L1 relapsed/refractory metastatic solid tumors. Recommend Isotype Controls: Human IgG4 (S228P) kappa, Isotype Control (HY-P99003).

CAS Number

2556646-63-8

Product Name Alternative

CLT-002 (Powder)

UNSPSC

12352203

Target

PD-1/PD-L1; TGF-beta/Smad

Related Pathways

Immunology/Inflammation; Stem Cell/Wnt; TGF-beta/Smad

Field of Research

Cancer

Smiles

[Visugromab(Powder)]

References & Citations

[1]Necchi A, et al. Neutralizing GDF-15 in muscle-invasive bladder cancer (MIBC) : A neoadjuvant immunotherapy trial of visugromab (CTL-002) in combination with the anti-PD1 antibody nivolumab (NEO-GDFATHER) [J]. 2023.|[2]Melero I, et al. Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours. Nature. 2025 Jan;637 (8048) :1218-1227.

Shipping Conditions

Room temperature

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-P99100A/

Scientific Category

Inhibitory Antibodies

Clinical Information

No Development Reported

Beschrijving

Visugromab (CTL-002) (Powder) is a GDF-15 neutralizing IgG4 mAb. Visugromab (Powder) has synergistic anticancer activity with the anti-PD1 antibody Nivolumab an

Specificaties

ProductnaamVisugromab (Powder)
Categorie
Beschikbare grootte1 Each
CatalogusnummerHY-P99100A